EICHORCondition: Uncontrolled Hypertension · Renal Denervation · Chronic Kidney Disease stage3 · Sponsor: University of Erlangen-Nürnberg Medical School
RDN-CKD Study is a prospective, randomized (1:1, central randomization), double-blind (unblinded interventionalist and blinded study team at each center), sham controlled, multicenter feasibility study. The purpose of the RDN-CKD Study is to demonstrate that renal denervation (RDN) effectively reduces 24-h ambulatory BP in 80 patients with chronic kidney disease (CKD) stage 3a or 3b.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Heinrich Heine University Düsseldorf, Nephrologie, Germany | Düsseldorf, Germany | — |
| Clinical Research Center, Department of Nephrology and Hypertension, University of Erlangen-Nuremberg | Erlangen, Germany | — |
| Klinik für Innere Medizin III, Kardiologie, Angiologie Und Internistische Intensivmedizin, Saarland University Hospital, Saarland University | Homburg, Germany | — |
| Clinical Research Center Nuremberg, Department of Nephrology, University Hospital Erlangen | Nuremberg, Germany | — |
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04264403